These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 10235031

  • 1. [Cerebral hemorrhage and "ecstasy"].
    Schlaeppi M, Prica A, de Torrenté A.
    Praxis (Bern 1994); 1999 Mar 25; 88(13):568-72. PubMed ID: 10235031
    [Abstract] [Full Text] [Related]

  • 2. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G, Bailly D, Boss V, Thomas P, Lestavel P, Goudemand M.
    Encephale; 2001 Mar 25; 27(2):198-202. PubMed ID: 11407274
    [Abstract] [Full Text] [Related]

  • 3. [Neuropsychiatric disorders induced by MDMA ("Ecstasy")].
    Bailly D.
    Encephale; 1999 Mar 25; 25(6):595-602. PubMed ID: 10668603
    [Abstract] [Full Text] [Related]

  • 4. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.
    Campbell GA, Rosner MH.
    Clin J Am Soc Nephrol; 2008 Nov 25; 3(6):1852-60. PubMed ID: 18684895
    [Abstract] [Full Text] [Related]

  • 5. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E.
    Biol Psychiatry; 2004 Sep 01; 56(5):349-55. PubMed ID: 15336517
    [Abstract] [Full Text] [Related]

  • 6. Hippocampal remodelling after MDMA neurotoxicity: a single case study.
    Nifosì F, Martinuzzi A, Toffanin T, Costanzo R, Vestri A, Battaglia M, Bertagnoni GE, Lupi A, Amistà P, Carollo C, Perini G.
    World J Biol Psychiatry; 2009 Sep 01; 10(4 Pt 3):961-8. PubMed ID: 18609419
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
    Garbino J, Henry JA, Mentha G, Romand JA.
    Vet Hum Toxicol; 2001 Apr 01; 43(2):99-102. PubMed ID: 11308131
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN, Spigset O, Slørdal L.
    Basic Clin Pharmacol Toxicol; 2008 Jan 01; 102(1):15-24. PubMed ID: 18047478
    [Abstract] [Full Text] [Related]

  • 14. [Persisting and late onset psychotic disorder due to consumption of ecstasy (MDMA)].
    Boné Pina I, Ramos Gorostiza P, Villalba Yllán P, Valle Fernández J.
    Actas Esp Psiquiatr; 2000 Jan 01; 28(1):61-5. PubMed ID: 10758429
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ecstasy (MDMA) and oral health.
    Brand HS, Dun SN, Nieuw Amerongen AV.
    Br Dent J; 2008 Jan 26; 204(2):77-81. PubMed ID: 18268544
    [Abstract] [Full Text] [Related]

  • 17. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment.
    Logan BK, Couper FJ.
    J Forensic Sci; 2001 Nov 26; 46(6):1426-33. PubMed ID: 11714155
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine.
    Payancé A, Scotto B, Perarnau JM, de Muret A, Bacq Y.
    Clin Res Hepatol Gastroenterol; 2013 Nov 26; 37(5):e109-13. PubMed ID: 23910059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.